Professional
Added to YB: 2025-01-23
Pitch date: 2025-01-23
SDGR [bullish]
Schrödinger, Inc.
-53.59%
current return
Author Info
Hunterbrook Media publishes investigative and global reporting with no ads or paywalls. Their mission is to bring visibility to under-covered regions and accountability to under-scrutinized sectors. Sign up for the newsletter.
Company Info
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally.
Market Cap
$907.3M
Pitch Price
$24.82
Price Target
110.00 (+855%)
Dividend
N/A
EV/EBITDA
-4.35
P/E
-8.72
EV/Sales
2.43
Sector
Health Care Technology
Category
growth
Schrödinger: The Nvidia Biotech Partner Jensen Huang Told To “Think Bigger”
SDGR: Physics-based drug discovery platform used by top pharma. AI integration enhancing capabilities. Software rev growing, high margins. 3 drugs in clinic, results in 2025. Novartis deal worth up to $2.3B. Valuation challenge due to hybrid software/biotech model. AI tailwinds: cheaper compute, AlphaFold, ML integration. $110 price target in 5 years.
Read full article (19 min)